1. Home
  2. INLX vs CLSD Comparison

INLX vs CLSD Comparison

Compare INLX & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • CLSD
  • Stock Information
  • Founded
  • INLX 1996
  • CLSD 2011
  • Country
  • INLX United States
  • CLSD United States
  • Employees
  • INLX N/A
  • CLSD N/A
  • Industry
  • INLX EDP Services
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • CLSD Health Care
  • Exchange
  • INLX Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • INLX 62.4M
  • CLSD 69.0M
  • IPO Year
  • INLX N/A
  • CLSD 2016
  • Fundamental
  • Price
  • INLX $13.42
  • CLSD $0.78
  • Analyst Decision
  • INLX
  • CLSD Strong Buy
  • Analyst Count
  • INLX 0
  • CLSD 5
  • Target Price
  • INLX N/A
  • CLSD $4.80
  • AVG Volume (30 Days)
  • INLX 4.5K
  • CLSD 161.6K
  • Earning Date
  • INLX 05-13-2025
  • CLSD 05-14-2025
  • Dividend Yield
  • INLX N/A
  • CLSD N/A
  • EPS Growth
  • INLX N/A
  • CLSD N/A
  • EPS
  • INLX N/A
  • CLSD N/A
  • Revenue
  • INLX $17,758,634.00
  • CLSD $3,764,000.00
  • Revenue This Year
  • INLX $7.58
  • CLSD N/A
  • Revenue Next Year
  • INLX N/A
  • CLSD $476.77
  • P/E Ratio
  • INLX N/A
  • CLSD N/A
  • Revenue Growth
  • INLX 3.21
  • CLSD N/A
  • 52 Week Low
  • INLX $5.85
  • CLSD $0.70
  • 52 Week High
  • INLX $16.50
  • CLSD $1.65
  • Technical
  • Relative Strength Index (RSI)
  • INLX 52.84
  • CLSD 37.94
  • Support Level
  • INLX $12.09
  • CLSD $0.75
  • Resistance Level
  • INLX $13.41
  • CLSD $0.91
  • Average True Range (ATR)
  • INLX 0.61
  • CLSD 0.05
  • MACD
  • INLX 0.03
  • CLSD -0.01
  • Stochastic Oscillator
  • INLX 65.14
  • CLSD 14.18

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: